Mdb Capital Holdings LLC

Company Overview

Business Model: MDB Capital Holdings, LLC operates as a foundational platform specializing in financing startups, partnering with co-founders, and fostering value creation, primarily through a "public venture capital" model. This involves identifying disruptive technologies, acting as founders, providing initial capital rounds (typically $5-$10 million), and facilitating subsequent financings ($20-$60 million) through public offerings or alternative value realization methods. The company supports a "Big Idea Pipeline" from discovery to commercialization, focusing on companies that exhibit "Tech Leadership Potential," "Platform Technology," are at an "Early Inflection Point," have "Clear Market Insertion," "Large Market Potential," and a "Strong IP Position."

Market Position: MDB Capital Holdings, LLC positions itself as a growth catalyst for community-driven micro and small-cap financings, enabling companies to scale and transition into public markets. Its wholly-owned subsidiary, PatentVest, Inc., provides integrated intellectual property solutions and strategy development, aiming to be a venture invention and commercialization intelligence platform. The company differentiates itself from traditional venture capital by its long-term involvement, acting as founders, and leveraging a community of sophisticated investors. Past examples of companies co-founded and taken public include Provention Bio, Inc., Cue BioPharma, Inc., and Pulse Biosciences, Inc., which achieved market values near or over $1 billion.

Recent Strategic Developments:

• Initial Public Offering: MDB Capital Holdings, LLC completed its IPO on September 20, 2023, selling 1,666,666 Class A Common Shares at $12.00 per share, raising gross proceeds of $19,999,992.
• eXoZymes Inc Deconsolidation: On November 14, 2024, eXoZymes Inc completed its IPO, reducing MDB Capital Holdings, LLC's ownership from approximately 60% to 47%. Consequently, eXoZymes Inc was deconsolidated and is now accounted for under the equity method.
• MDB Minnesota One, Inc. Formation: MDB Minnesota One, Inc. was created in mid-2024 to develop a small molecule anti-senescence platform, securing an exclusive Patent and Know-How License Agreement with Mayo Foundation for Medical Education and Research on July 1, 2024.
• Public Ventures, LLC Self-Clearing: In January 2024, Public Ventures, LLC expanded its capabilities to act as a licensed self-clearing firm for U.S. equity securities.
• PatentVest, Inc. Law Firm License: On September 20, 2022, PatentVest, Inc. was licensed by the Supreme Court of the State of Arizona to practice law as an Alternative Business Structure, providing legal services related to intellectual property matters.

Geographic Footprint: MDB Capital Holdings, LLC's principal executive offices are located in Addison, Texas. Its operations are primarily U.S.-based, with a human capital development platform and outsourced services provided by MDB Capital, S.A., an affiliated Nicaraguan company.

Financial Performance

Revenue Analysis

Profitability Metrics:

• Operating Margin: -1327.2%
• Net Margin: 542.0%

Investment in Growth:

• R&D Expenditure: $1,467,871 (67.9% of total operating income, net)
• Capital Expenditures: $546,079 (Purchases of property and equipment)
• Strategic Investments: MDB Minnesota One, Inc. received capital infusions of $176,840 in 2024. A gain on deconsolidation of eXoZymes Inc of $39,307,217 was recognized in 2024.

Business Segment Analysis

Broker Dealer and Intellectual Property Service Segment (Public Ventures, LLC and PatentVest, Inc.)

Financial Performance:

• Revenue (Total operating income, net): $2,157,273 (-63.6% YoY)
• Operating Margin: -275.2% (Net operating loss of $(5,937,544) on revenue of $2,157,273)
• Key Growth Drivers: Community-driven micro and small-cap financings, expansion into self-clearing operations, intellectual property strategy development, and venture invention and commercialization intelligence.

Product Portfolio:

• Brokerage services, including trade-based commission income, net realized gains and losses from proprietary trades, and stock loan income.
• Underwriting and private placement services for early-stage technology and business platforms.
• Intellectual property validation services, IP strategy development, and legal services related to intellectual property matters through PatentVest, Inc.

Market Dynamics:

• Focuses on the microcap and small-cap public venture market, leveraging a community of sophisticated individual investors and entrepreneurs.
• Aims to provide a transparent and liquid method for venture investing in public markets, addressing a gap left by traditional brokerage firms.
• Faces competition from traditional venture capital firms, other microcap and small-cap funds, and investment banks.

Technology Segment (MDB Minnesota One, Inc. and eXoZymes Inc)

Financial Performance:

• Revenue (Total operating income, net): $0 (-100.0% YoY)
• Operating Margin: -Inf% (Net operating loss of $(4,903,081) on revenue of $0)
• Key Growth Drivers: Development of the M1 Platform (small molecule anti-senescence) and eXoZymes Inc's cell-free technology.

Product Portfolio:

• MDB Minnesota One, Inc.: Developing a small molecule anti-senescence platform for pharmaceutical drugs or other products to aid in longevity and inhibit age-related diseases, based on licensed technology from Mayo Foundation for Medical Education and Research. Currently in pre-clinical development.
• eXoZymes Inc: Developing cell-free technology to optimize biological processes for chemical production. (Deconsolidated as of November 14, 2024, now an equity method investment).

Market Dynamics:

• MDB Minnesota One, Inc. operates in the rapidly growing and competitive global longevity and anti-senescence therapy market, projected to reach nearly $45 billion by 2030.
• Products are novel and will likely be subject to regulatory approvals (e.g., FDA New Drug Application).
• Faces competition from large pharmaceutical and nutraceutical companies and research institutions.

Capital Allocation Strategy

Shareholder Returns:

• Share Repurchases: Not disclosed.
• Dividend Payments: MDB Capital Holdings, LLC has not paid any dividends or made any distributions related to its equity securities to date.
• Future Capital Return Commitments: The company intends to distribute partner company securities (after they go public), rights to purchase equity of these companies, and/or cash and other property to shareholders from time to time. This strategy is partly driven by the operational plan to avoid being subject to the Investment Company Act of 1940.

Balance Sheet Position (as of December 31, 2024):

• Cash and Equivalents: $21,281,233 (includes $843,741 cash segregated in compliance with regulations).
• Total Debt: $0 (no outstanding indebtedness under the revolving credit facility).
• Net Cash Position: $21,281,233.
• Debt Maturity Profile: A revolving credit facility of up to $2,000,000 matures July 26, 2025, with a variable interest rate (7.75% at inception). No drawdowns have been made.

Cash Flow Generation (Year Ended December 31, 2024):

• Operating Cash Flow: $(9,037,746) (Net cash used in operating activities).
• Free Cash Flow: Not explicitly calculated.
• Cash Conversion Metrics: Not explicitly disclosed.

Operational Excellence

Production & Service Model: MDB Capital Holdings, LLC employs a "public venture capital" model, acting as founders for early-stage technology and life sciences companies. This involves a "Rational Design Process For New Companies" to establish corporate and financial foundations, develop business and IP strategies, and recruit management. The company provides a continuum of support from inception through growth, aiming for market leadership.

Supply Chain Architecture: Key Suppliers & Partners:

• Outsourced Services: MDB Capital, S.A. (Nicaraguan affiliated company) provides administrative, back-office, research, and analytical support services for Public Ventures, LLC, PatentVest, Inc., and partner companies.
• Clearing Services: Public Ventures, LLC operates on a fully disclosed basis with Interactive Brokers, LLC, which acts as its clearing firm and custodian. Public Ventures, LLC also began self-clearing U.S. equity securities in January 2024, requiring contractual arrangements with Depository Trust Clearing Corporation, National Securities Clearing Corporation, and a settlement bank (Lakeside Bank).
• Technology Licensing: MDB Minnesota One, Inc. has an exclusive Patent and Know-How License Agreement with Mayo Foundation for Medical Education and Research for its anti-senescence platform.

Facility Network:

• Principal Office: Addison, Texas (approximately 5,500 square feet, lease expires July 2030).
• Research & Development: MDB Minnesota One, Inc. is in the pre-clinical development stage for its anti-senescence platform, leveraging licensed technology.

Operational Metrics:

• Public Ventures, LLC's self-clearing operations require maintaining specific financial, operational, and systems capacities, including a core clearing system, an order management system, and a corporate communications system.
• Public Ventures, LLC maintains net capital of $10,736,754 at December 31, 2024, exceeding the minimum requirement by $10,486,754, and a ratio of aggregate indebtedness to net capital of 0.61 to 1 (compared to a maximum allowable of 15 to 1).

Market Access & Customer Relationships

Go-to-Market Strategy: Distribution Channels:

• Direct Sales: Public Ventures, LLC facilitates IPOs and other financings for partner companies, engaging directly with a "community of more than 500 sophisticated investors."
• Channel Partners: PatentVest, Inc. offers its IP services directly to technology companies and supports MDB Capital Holdings, LLC's internal partner company selection and development process.

Customer Portfolio: Enterprise Customers:

• Partner Companies: MDB Capital Holdings, LLC's core business involves co-founding and developing early-stage technology and life sciences companies.
• Strategic Partnerships: MDB Minnesota One, Inc.'s collaboration with Mayo Foundation for Medical Education and Research for technology development. Customer Concentration: Not explicitly quantified, but the business model focuses on a select number of "Big Idea Companies" and a community of investors.

Geographic Revenue Distribution:

• United States: Primary operational and revenue generation region for brokerage and IP services.

Competitive Intelligence

Market Structure & Dynamics

Industry Characteristics: The market for early-stage capital is highly competitive. MDB Capital Holdings, LLC aims to address a perceived gap in public markets for early-stage companies by fostering a community of long-term-oriented investors for microcap and small-cap companies. The longevity and anti-senescence therapy market (relevant to MDB Minnesota One, Inc.) is rapidly growing and changing, projected to reach nearly $45 billion by 2030.

Competitive Positioning Matrix:

Direct Competitors

Primary Competitors:

• Traditional Venture Capital Firms: Larger, with greater brand recognition, longer operating histories, established business relationships, and access to greater capital.
• Other Funds Specializing in Microcap and Small Cap Investing: Compete for capital and investment opportunities in the target market.
• Investment Banks Focusing on Microcap and Small Cap Companies: Offer similar financing and advisory services.
• For MDB Minnesota One, Inc.: Large pharmaceutical and nutraceutical companies and research institutions working in anti-senescence technology.

Competitive Response Strategy: MDB Capital Holdings, LLC's "public venture capital" model, which involves acting as founders, providing long-term strategic involvement, and leveraging a dedicated investor community, is its primary competitive response. This approach aims to provide more liquidity, efficiency, transparency, and better investor protections than traditional venture capital.

Risk Assessment Framework

Strategic & Market Risks

Market Dynamics:

• Partner Company Performance: Success is highly dependent on the ability to select and nurture partner companies, which are early-stage with limited operating histories and uncertain commercial viability. Failure of one or more partner companies could significantly reduce asset value.
• Capital Availability: Reliance on raising additional capital for MDB Capital Holdings, LLC and its partner companies, which may not be available on favorable terms or at all, potentially limiting growth or forcing business curtailment.
• Market Volatility: The price of Class A Common Shares may be volatile, affected by overall stock market fluctuations, investor demand, and performance of comparable companies, potentially leading to significant declines. Technology Disruption:
• Product Development Risk: New technologies developed by partner companies may not be successfully developed, commercialized, or accepted in the marketplace, leading to losses.
• Rapidly Changing Markets: MDB Minnesota One, Inc. operates in a fast-evolving anti-senescence market, requiring continuous assessment and timely product development to avoid obsolescence. Customer Concentration:
• eXoZymes Inc Investment: The equity investment in eXoZymes Inc represents a significant portion of total assets, making MDB Capital Holdings, LLC susceptible to fluctuations in its value and performance.

Operational & Execution Risks

Supply Chain Vulnerabilities:

• Outsourcing Dependency: Reliance on MDB Capital, S.A. (Nicaragua) for outsourced services, which could be disrupted by U.S. sanctions or political instability in Nicaragua, leading to increased costs and operational challenges. Capacity Constraints:
• Talent Acquisition & Retention: Difficulty in attracting and retaining highly qualified managerial, scientific, and technical personnel at both MDB Capital Holdings, LLC and its partner companies, particularly in specialized fields like anti-senescence.
• Scaling Operations: PatentVest, Inc. faces challenges in scaling its business while maintaining service quality and brand awareness.

Financial & Regulatory Risks

Market & Financial Risks:

• Liquidity Issues: MDB Capital Holdings, LLC's business model does not rely on operating cash flows from partner companies, depending instead on cash on hand, Public Ventures, LLC dividends, and capital raising activities. Inability to monetize holdings or raise capital could lead to liquidity issues.
• Concentrated Equity Investment: Significant and concentrated equity investment in eXoZymes Inc, whose public market performance is unpredictable and could lead to non-cash losses or impairment charges. Regulatory & Compliance Risks:
• Broker-Dealer Regulation: Public Ventures, LLC is subject to extensive and evolving regulations by the SEC, FINRA, and state securities regulators, covering securities transactions, capital requirements, record-keeping, client relationships, and anti-money laundering (USA PATRIOT Act).
• Self-Clearing Regulation: Public Ventures, LLC's self-clearing operations are subject to additional regulations from the SEC, FINRA, Depository Trust Clearing Corporation, and National Securities Clearing Corporation, requiring robust financial, operational, and systems capacities.
• Investment Company Act of 1940: MDB Capital Holdings, LLC must manage its assets to avoid being deemed an investment company, potentially forcing it to forego attractive opportunities or make non-optimal asset management decisions.
• Data Privacy Laws: Subject to stringent and evolving data privacy laws (e.g., GLBA, CCPA, CPRA), with non-compliance risking fines, lawsuits, reputational damage, and increased operational costs.
• Arizona ABS Law Firm Regulation: PatentVest, Inc.'s legal services are subject to Arizona Supreme Court rules for Alternative Business Structures, requiring strict adherence to ethical and legal provisions, which may conflict with business interests.

Geopolitical & External Risks

Geopolitical Exposure:

• U.S. and Nicaraguan Political Environment: Operations are exposed to political, economic, and regulatory changes in both countries, particularly U.S. sanctions on Nicaraguan businesses, which could disrupt outsourced services. Trade Relations:
• Sanctions Impact: Executive Orders imposing sanctions on Nicaragua could prohibit or hinder service arrangements with MDB Capital, S.A., increasing costs and requiring replacement personnel.

Innovation & Technology Leadership

Research & Development Focus: Core Technology Areas:

• Anti-Senescence Platform: MDB Minnesota One, Inc. is focused on developing a small molecule anti-senescence platform for pharmaceutical drugs to address longevity and age-related diseases, based on licensed technology from Mayo Foundation for Medical Education and Research.
• Cell-Free Technology: eXoZymes Inc (now an equity method investment) develops cell-free technology to optimize biological processes for chemical production.
• Patent Database & Software: PatentVest, Inc. has built a proprietary patent database (over 148 million patents across 116 countries) and software platform for invention and commercialization intelligence. Innovation Pipeline:
• Big Idea Pipeline: MDB Capital Holdings, LLC maintains a continuous process to scout potential tech ideas from various sources, identifying approximately 250 relevant technologies, narrowing down to about 50 active "Big Idea Companies," with approximately ten reaching advanced stages, and two currently in active negotiations for partnership or investment.

Intellectual Property Portfolio:

• Patent Strategy: PatentVest, Inc. guides technology companies through IP law, providing IP strategy development, defining invention boundaries, and optimizing patent claims to secure competitive advantages. MDB Capital Holdings, LLC's investment criteria emphasize a "Strong IP Position" for partner companies.
• Licensing Programs: MDB Minnesota One, Inc. holds an exclusive license for patent rights and a non-exclusive license for associated technology from Mayo Foundation for Medical Education and Research.
• IP Litigation: Partner companies face risks of infringement claims and the need to defend their proprietary rights, which can be costly and divert resources.

Technology Partnerships:

• Strategic Alliances: MDB Minnesota One, Inc.'s license agreement with Mayo Foundation for Medical Education and Research is a key technology partnership.

Leadership & Governance

Executive Leadership Team

Leadership Continuity: The company relies heavily on its senior professionals, particularly directors and senior management, for sourcing technologies, deploying capital, and executing strategy. The loss of key personnel could harm the business.

Board Composition: The board of directors consists of eight persons. Four directors (Susanne Meline, Daniel Torpey, Matthew Hayden, and Sean Magennis) are independent within the meaning of Nasdaq's rules. Daniel Torpey is a "financial expert" and chairs the Audit Committee. MDB Capital Holdings, LLC is a "controlled company" under Nasdaq rules due to the Class B Common Shares held by Christopher Marlett and Anthony DiGiandomenico, which represent 90.8% of aggregate voting authority. As a controlled company, it is exempt from certain corporate governance requirements, such as having a majority independent board, a compensation committee, and a director nominations committee.

Human Capital Strategy

Workforce Composition:

• Total Employees: Approximately 16 full-time employees of MDB Capital Holdings, LLC, employed directly or indirectly through MDB CG Management Company.
• Geographic Distribution: Primarily U.S.-based, with outsourced services from MDB Capital, S.A. in Nicaragua.
• Skill Mix: Includes managerial, scientific, and technical personnel, with a focus on specialized backgrounds for partner companies (e.g., anti-senescence space for MDB Minnesota One, Inc.).

Talent Management: Acquisition & Retention:

• Hiring Strategy: Aims to attract and retain highly qualified personnel for both MDB Capital Holdings, LLC and its partner companies.
• Retention Metrics: Not explicitly disclosed.
• Employee Value Proposition: Uses equity grants (e.g., Restricted Stock Units) as part of compensation to align employee interests with shareholders and partner company stakeholders.

Diversity & Development: Not explicitly detailed in the filing.

Business Cyclicality & Seasonality

Demand Patterns:

• Seasonal Trends: Not explicitly detailed, but broker-dealer activity and fee income are noted to fluctuate. Grant funding for R&D is also expected to fluctuate.
• Economic Sensitivity: The company acknowledges that an economic recession would likely impact the general business environment and capital markets, which could affect MDB Capital Holdings, LLC.
• Industry Cycles: Not explicitly detailed.

Planning & Forecasting: Not explicitly detailed beyond general business and financing plans.

Regulatory Environment & Compliance

Regulatory Framework: Industry-Specific Regulations:

• Broker-Dealer Regulation: Public Ventures, LLC is subject to extensive regulation by the SEC, FINRA, and state securities regulators, covering securities transactions, capital requirements, record-keeping, client relationships, and anti-money laundering (USA PATRIOT Act).
• Self-Clearing Regulation: Public Ventures, LLC's self-clearing operations are subject to additional regulations from the SEC, FINRA, Depository Trust Clearing Corporation, and National Securities Clearing Corporation, requiring robust financial, operational, and systems capacities.
• Arizona ABS Law Firm Regulation: PatentVest, Inc. is licensed as an Alternative Business Structure law firm in Arizona, subject to the Arizona Supreme Court's rules and ethical provisions for law firms, including confidentiality, conflicts of interest, and client fund handling. International Compliance:
• U.S. Foreign Corrupt Practices Act: Prohibits U.S. corporations and individuals from engaging in certain activities to obtain or retain business abroad.

Trade & Export Controls:

• Export Restrictions: The company is exposed to risks from U.S. Executive Orders imposing sanctions on Nicaraguan businesses, which could disrupt outsourced service arrangements with MDB Capital, S.A.

Legal Proceedings:

• MDB Capital Holdings, LLC is not currently subject to any material legal proceedings, but may become a party to various legal proceedings in the ordinary course of business, including regulatory reviews that could result in penalties. Public Ventures, LLC is currently subject to a review of past broker-dealer activities, with an unknown outcome.

Tax Strategy & Considerations

Tax Profile:

• Entity Classification: MDB Capital Holdings, LLC is treated as a partnership for U.S. federal income tax purposes, generally not subject to entity-level taxation, with income/loss flowing through to shareholders. It aims to maintain "qualifying income" above 90% to avoid corporate taxation.
• Subsidiary Taxation: Public Ventures, LLC, MDB Management, PatentVest, Inc., and MDB Minnesota One, Inc. are Subchapter C-corporations and are subject to federal and state income taxes.
• Effective Tax Rate: For the taxable entities, the effective tax rate was (0.00)% in 2024 and (1.69)% in 2023.
• Geographic Tax Planning: Not explicitly detailed beyond the general tax profile.
• Tax Reform Impact: Not explicitly detailed.

Insurance & Risk Transfer

Risk Management Framework:

• MDB Capital Holdings, LLC and its subsidiaries, including Public Ventures, LLC, have implemented a comprehensive cybersecurity program to identify, monitor, and mitigate cybersecurity risks, managed by the information technology department and integrated into the overall risk management framework.
• Management provides regular cybersecurity updates to the Audit Committee.

Insurance Coverage:

• The company may not have adequate insurance coverage for liabilities resulting from cyberattacks or other security breaches.
• MDB Capital Holdings, LLC does not maintain key-man insurance policies for its executive officers or employees.

Risk Transfer Mechanisms:

• Indemnification Provisions: Public Ventures, LLC indemnifies its clearing broker for customer account losses. MDB Capital Holdings, LLC provides indemnification agreements to its directors and executive officers, and similar agreements are arranged for partner company officers and directors.